Determinants of treatment motivation among tuberculosis patients at a community health center in Medan, North Sumatra, Indonesia
Abstract
Objective: The objective of this study is to identify and determine the factors influencing patients’ motivation to undergo tuberculosis (TB) treatment at a community health center in Medan, North Sumatra, Indonesia.
Method: A cross-sectional study was conducted using a total sampling design. The study included 92 pulmonary TB patients aged 18-55 years who received treatment at a community health center in Medan, Indonesia. Inclusion criteria include consenting patients (18-55 years) with pulmonary TB in the continuation phase, including new, incomplete cure, or re-treatment cases. Patients with mental disorders or multidrug-resistant TB (MDR-TB) were excluded. Data were collected using a pre-tested questionnaire and analyzed using bivariate and multivariate ordinal regression models to determine factors associated with treatment motivation.
Results: Univariate analysis showed that self-efficacy [odds ratio (OR)=1.131, plt;0.001] and perceived quality of health services (OR=1.149, p=0.009) were significantly associated with patients’ motivation for treatment. In the multivariate model, self-efficacy remained the strongest factor influencing patients’ motivation for TB treatment (OR=1.20, p=0.003).
Conclusion: Self-efficacy was the main determinant of patients’ motivation for TB treatment. These findings highlight the importance of enhancing patients’ self-efficacy through interventions that empower them to take control of their
treatment.
Keywords
Motivation, Tuberculosis, Community health center, Self efficacy
Supporting Institution
The authors received financial assistance from Research and Community Service Nommensen HKBP University.
Ethical Statement
This study obtained ethical approval from the Faculty of Medicine at University of Nommensen HKBP after undergoing a thorough review process to ensure compliance with ethical
standards for human subjects. The approval was granted under approval number 558/KEPK/FK/ IX/2023.
Thanks
Directorate of Research and Community Services, HKBP Nommensen University
Sentosa Baru Community Health Center, Medan
References
- 1. World Health Organization. Global Tuberculosis Report 2022. In: WHO [online]. Available at: https://www.who.int/publications/i/item/9789240061729. Accessed November 4, 2024.
- 2. Ministry of Health Republic of Indonesia. The 2022 Annual Report on the National TB Program. Jakarta: Ministry of Health Republic of Indonesia; 2023.
- 3. Central Bureau of Statistics of North Sumatra Province. Jumlah Kasus Penyakit Menurut Kabupaten/Kota dan Jenis Penyakit di Provinsi Sumatera Utara. In: BPS Sumut [online]. Available at: https://sumut.bps.go.id/id/statistics-table/1/MzA2NCMx/jumlah-kasus-penyakit-menurut-kabupaten-kota-dan-jenis-penyakit-di-provinsi-sumatera-utara-2022.html. Accessed November 8, 2024.
- 4. Naidoo K, Perumal R, Cox H, et al. The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience. Lancet Infect Dis 2024;24(9):e559-e575.
- 5. Liebenberg D, Gordhan B, Kana B. Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management. Front Cell Infect Microbiol 2022;12:943545.
- 6. Alwi N, Fitri A, Ambarita R. Hubungan motivasi dengan kepatuhan minum obat anti tuberkulosis (OAT) pada pasien tuberkulosis. Jurnal Keperawatan Abdurrab 2021;5(1):63-66.
- 7. Fishbach A, Woolley K. The structure of intrinsic motivation. Annu Rev Organ Psychol Organ Behav 2022;9:339-363.
- 8. Elmuttalut M. The key factors influencing tuberculosis treatment outcomes: A literature review. Int J Recent Innov Med Clin Res 2024;6(3):76-79.
- 9. Fang XH, Dan YL, Liu J, et al. Factors influencing completion of treatment among pulmonary tuberculosis patients. Patient Prefer Adherence 2019;13:491-496.
- 10. Purgiantari P, Suryoputri M, Endriastuti N. The relationship between knowledge level and adherence to anti-tuberculosis treatment at primary health centers (Puskesmas) in Pekalongan city, Central Java, Indonesia. Acta Pharm Indones 2022;10(2):56-61.